Table 2 Multivariable analysis for the risk of dying from acute lymphoblastic leukaemia for patients aged < 18 years in the Netherlands between 1990 and 2015.

From: Progress against childhood and adolescent acute lymphoblastic leukaemia in the Netherlands, 1990–2015

 

N

HRa

95% CI

P value

Period

 1990–94

481

Ref.

  

 1995–99

589

0.9

0.7–1.2

0.56

 2000–04

640

0.7

0.5–0.9

0.01

 2005–09

585

0.5

0.1–0.3

<0.01

 2010–15

702

0.4

0.1–0.3

<0.01

Sex

 Male

1744

Ref.

  

 Female

1253

0.9

0.7–1.1

0.19

Age groups (years)

 0

90

8.2

5.8–12

<0.01

 1–4

1385

Ref.

  

 5–9

796

1

0.8–1.4

0.79

 10–14

479

2.1

1.6–2.8

<0.01

 15–17

247

3.5

2.6–4.7

<0.01

Immunophenotype

 BCP-ALL

2562

Ref.

  

 T-cell ALL

424

1.9

1.5–2.4

<0.01

 Unknown

11

ND

  
  1. BCP-ALL B-cell precursor acute lymphoblastic leukaemia, HR hazard ratio, CI confidence interval, ND not done.
  2. aIn this multivariable analysis, each covariate is simultaneously adjusted for all other covariates and follow-up time. Hazard ratios represent risk of death within 5 years from diagnosis compared to the reference category.